In our previous work, we developed CD99-specific CAR-T cells that exhibited potent antitumor activity against various tumor types [2], while showing a favorable safety profile with only minimal cytotoxicity toward activated T cells during in vitro culture [2]. The gene discussed is CD99; the disease is neoplasm.